-
2024COVID-19 Vaccine Effectiveness in Autumn and Winter 2022 to 2023 Among Older Europeans, JAMA Network Open, 2024, 7 (7), pp.e2419258. ⟨10.1001/jamanetworkopen.2024.19258⟩.
-
2024COVID-19 Vaccine Effectiveness in Autumn and Winter 2022 to 2023 Among Older Europeans., JAMA Netw Open 2024 Jul; 7(7): e2419258.
-
2024Serological responses against seasonal influenza viruses in patients with multiple myeloma treated or untreated with daratumumab after two doses of tetravalent vaccine., Int J Infect Dis 2024 May; 146(): 107108.
-
2024COVID-19 vaccine effectiveness against symptomatic infection with SARS-CoV-2 BA.1/BA.2 lineages among adults and adolescents in a multicentre primary care study, Europe, December 2021 to June 2022, Eurosurveillance, 2024, 29 (13), pp.2300403. ⟨10.2807/1560-7917.es.2024.29.13.2300403⟩.
-
2024COVID-19 vaccine effectiveness against symptomatic infection with SARS-CoV-2 BA.1/BA.2 lineages among adults and adolescents in a multicentre primary care study, Europe, December 2021 to June 2022., Euro Surveill 2024 Mar; 29(13): .
-
2024Interim 2023/24 influenza A vaccine effectiveness: VEBIS European primary care and hospital multicentre studies, September 2023 to January 2024, Eurosurveillance, 2024, 29 (8), ⟨10.2807/1560-7917.es.2024.29.8.2400089⟩.
-
2024Interim 2023/24 influenza A vaccine effectiveness: VEBIS European primary care and hospital multicentre studies, September 2023 to January 2024., Euro Surveill 2024 Feb; 29(8): .
-
2024Influenza vaccine effectiveness in Europe: Results from the 2022–2023 VEBIS (Vaccine Effectiveness, Burden and Impact Studies) primary care multicentre study, Influenza and Other Respiratory Viruses, 2024, 18 (1), pp.e13243. ⟨10.1111/irv.13243⟩.
-
2024Influenza vaccine effectiveness in Europe: Results from the 2022-2023 VEBIS (Vaccine Effectiveness, Burden and Impact Studies) primary care multicentre study., Influenza Other Respir Viruses 2024 Jan; 18(1): e13243.
-
2023Seasonal and inter‐seasonal RSV activity in the European Region during the COVID‐19 pandemic from autumn 2020 to summer 2022, Influenza and Other Respiratory Viruses, 2023, 17 (11), pp.e13219. ⟨10.1111/irv.13219⟩.
-
2023Seasonal and inter-seasonal RSV activity in the European Region during the COVID-19 pandemic from autumn 2020 to summer 2022., Influenza Other Respir Viruses 2023 Nov; 17(11): e13219.
-
2023Investigations into SARS-CoV-2 and other coronaviruses on mink farms in France late in the first year of the COVID-19 pandemic, PLoS ONE, 2023, 18 (8), pp.e0290444. ⟨10.1371/journal.pone.0290444⟩.
-
2023Emergence and evolution of the Omicron SARS-CoV-2 variant in the island of Martinique, Infectious Diseases Now, 2023, 53 (4), pp.104690. ⟨10.1016/j.idnow.2023.104690⟩.
-
2023Emergence and evolution of the Omicron SARS-CoV-2 variant in the island of Martinique., Infect Dis Now 2023 Jun; 53(4): 104690.
-
2023Investigations on SARS-CoV-2 and other coronaviruses in mink farms in France at the end of the first year of COVID-19 pandemic, 2023.
-
2023Investigations on SARS-CoV-2 and other coronaviruses in mink farms in France at the end of the first year of COVID-19 pandemic., bioRxiv 2023 Feb; (): .
-
2023Investigations into SARS-CoV-2 and other coronaviruses on mink farms in France late in the first year of the COVID-19 pandemic., PLoS One 2023 ; 18(8): e0290444.
-
2022Capturing SARS-CoV-2 from patient samples with low viral abundance: a comparative analysis, 2022 12:19274.
-
2021Impact of original, B.1.1.7, and B.1.351/P.1 SARS-CoV-2 lineages on vaccine effectiveness of two doses of COVID-19 mRNA vaccines: Results from a nationwide case-control study in France., Lancet Reg Health Eur 2021 Sep; 8(): 100171.
-
2021Performing point-of-care molecular testing for SARS-CoV-2 with RNA extraction and isothermal amplification, PLOS ONE, 16(1), e0243712 - January 2021.
-
2020A comparison of four serological assays for detecting anti–SARS-CoV-2 antibodies in human serum samples from different populations, Science Translational Medicine, 2020, 12 (559), pp.eabc3103. ⟨10.1126/scitranslmed.abc3103⟩.
-
2020Highly performing point-of-care molecular testing for SARS-CoV-2 with RNA extraction and isothermal amplification., medRxiv 2020.08.01.20166538.
-
2020Introductions and early spread of SARS-CoV-2 in France, 24 January to 23 March 2020., Euro Surveill. 2020 07; 25(26): .
-
2015Early estimates of 2014/15 seasonal influenza vaccine effectiveness in preventing influenza-like illness in general practice using the screening method in France, Hum Vaccin Immunother 2015 Jul;11(7):1621-5.
-
2015Erratum to: Genetic Adaptation of Influenza A Viruses in Domestic Animals and Their Potential Role in Interspecies Transmission: A Literature Review, Ecohealth 2015 May;.
-
2015Start of the 2014/15 influenza season in Europe: drifted influenza A(H3N2) viruses circulate as dominant subtype, Euro Surveill. 2015;20(4).
-
2015Genetic Adaptation of Influenza A Viruses in Domestic Animals and Their Potential Role in Interspecies Transmission: A Literature Review, Ecohealth 2015 Jan;.
-
2014Influenza at the animal-human interface: a review of the literature for virological evidence of human infection with swine or avian influenza viruses other than A(H5N1), Euro Surveill. 2014;19(18).
-
2013Middle East respiratory syndrome coronavirus: quantification of the extent of the epidemic, surveillance biases, and transmissibility, Lancet Infect Dis 2014 Jan;14(1):50-56.
-
2013Complications and factors associated with severity of influenza in hospitalized children and adults during the pandemic wave of A(H1N1)pdm2009 infections–the Fluco French cohort, J. Clin. Virol. 2013 Sep;58(1):114-9.
-
2013First cases of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infections in France, investigations and implications for the prevention of human-to-human transmission, France, May 2013, Euro Surveill. 2013;18(24).
-
2013Clinical features and viral diagnosis of two cases of infection with Middle East Respiratory Syndrome coronavirus: a report of nosocomial transmission, Lancet 2013 Jun;381(9885):2265-72.
-
2013Guidance for clinical and public health laboratories testing for influenza virus antiviral drug susceptibility in Europe, J. Clin. Virol. 2013 May;57(1):5-12.
-
2012Spatiotemporal circulation of influenza viruses in 5 African countries during 2008-2009: a collaborative study of the Institut Pasteur International Network, J. Infect. Dis. 2012 Dec;206 Suppl 1:S5-13.
-
2012I223R mutation in influenza A(H1N1)pdm09 neuraminidase confers reduced susceptibility to oseltamivir and zanamivir and enhanced resistance with H275Y, PLoS ONE 2012;7(8):e37095.
-
2012Oseltamivir-zanamivir bitherapy compared to oseltamivir monotherapy in the treatment of pandemic 2009 influenza A(H1N1) virus infections, Antiviral Res. 2012 Nov;96(2):130-7.
-
2012HI responses induced by seasonal influenza vaccination are associated with clinical protection and with seroprotection against non-homologous strains, Vaccine 2012 Jul;30(35):5262-9.
-
2012Incidence of H1N1 2009 virus infection through the analysis of paired plasma specimens among blood donors, France, PLoS ONE 2012;7(3):e33056.
-
2012Factors associated with clinical and virological response in patients treated with oseltamivir or zanamivir for influenza A during the 2008-2009 winter, Clin. Microbiol. Infect. 2013 Feb;19(2):196-203.
-
2011S-OtrH3N2 viruses: use of sequence data for description of the molecular characteristics of the viruses and their relatedness to previously circulating H3N2 human viruses, Euro Surveill. 2011;16(50):20039.
-
2011Highly heterogeneous temperature sensitivity of 2009 pandemic influenza A(H1N1) viral isolates, northern France, Euro Surveill. 2011 Oct;16(43).
-
2011Surveillance trends of the 2009 influenza A(H1N1) pandemic in Europe, Euro Surveill. 2011;16(26).
-
2011Enhanced humoral and cell-mediated immune responses after immunization with trivalent influenza vaccine adjuvanted with cationic liposomes, Vaccine 2011 Aug;29(37):6283-91.
-
2011Monitoring epidemic viral respiratory infections using one-step real-time triplex RT-PCR targeting influenza A and B viruses and respiratory syncytial virus., J Med Virol 2011 Apr; 83(4): 695-701.
-
2010Initial surveillance of 2009 influenza A(H1N1) pandemic in the European Union and European Economic Area, April-September 2009, Euro Surveill. 2010 Dec;15(49).
-
2010Efficacy of oseltamivir-zanamivir combination compared to each monotherapy for seasonal influenza: a randomized placebo-controlled trial, PLoS Med. 2010;7(11):e1000362.
-
2009Molecular epidemiology of clade 1 influenza A viruses (H5N1), southern Indochina peninsula, 2004-2007, Emerging Infect. Dis. 2009 Oct;15(10):1641-4.
-
2009Kinetics of nasopharyngeal shedding of novel H1N1 (swine-like) influenza A virus in an immunocompetent adult under oseltamivir therapy., Clin Microbiol Infect 2009 Dec; 15(12): 1189-91.
-
2009Preliminary analysis of influenza A(H1N1)v individual and aggregated case reports from EU and EFTA countries, Euro Surveill. 2009 Jun;14(23):19238.
-
2009[Glycopeptide-resistant enterococci carriage: Are actual isolation and identification techniques sufficient?], Pathol. Biol. 2011 Jun;59(3):146-50.
-
2009Oseltamivir-resistant influenza virus A (H1N1), Europe, 2007-08 season, Emerging Infect. Dis. 2009 Apr;15(4):552-60.
-
2009Guillain-Barré syndrome and influenza virus infection, Clin. Infect. Dis. 2009 Jan;48(1):48-56.
-
2008Enzymatic properties of the neuraminidase of seasonal H1N1 influenza viruses provide insights for the emergence of natural resistance to oseltamivir., PLoS Pathog 2008 Jul; 4(7): e1000103.
-
2007Acute bilateral uveitis associated with an active human herpesvirus-6 infection, J. Infect. 2007 Apr;54(4):e237-40.
-
2006Identification of genotype 1 hepatitis E virus in samples from swine in Cambodia, J. Clin. Microbiol. 2006 Sep;44(9):3440-2.
-
2006Validation of single real-time TaqMan PCR assay for the detection and quantitation of four major genotypes of hepatitis E virus in clinical specimens, J. Med. Virol. 2006 Aug;78(8):1076-82.
-
2005Genetic heterogeneity of hepatitis E virus in Darfur, Sudan, and neighboring Chad, J. Med. Virol. 2005 Dec;77(4):519-21.
-
2004Evidence for hepatitis E virus quasispecies, J. Gen. Virol. 2004 Nov;85(Pt 11):3189-94.
-
2003Interactions of rotavirus VP4 spike protein with the endosomal protein Rab5 and the prenylated Rab acceptor PRA1, J. Virol. 2003 Jun;77(12):7041-7.
-
2002Rafts promote assembly and atypical targeting of a nonenveloped virus, rotavirus, in Caco-2 cells, J. Virol. 2002 May;76(9):4591-602.
-
2001Bovine rotavirus nonstructural protein 4 produced by Lactococcus lactis is antigenic and immunogenic, Appl. Environ. Microbiol. 2001 Apr;67(4):1423-8.